Miriam A. Royo
Barcelona Science Park
Barcelona, CT 08028, Spain
Barcelona, CT 08028, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
cis-γ-Amino-L-proline peptides as chemical probes of amyloidogenic processing in neurons and APP/PS1 mice.
Journal: Bioorganic chemistry
Published: April 20, 2026
A non-hydrolysable peptidomimetic for mitochondrial targeting.
Journal: Journal of materials chemistry. B
Published: February 10, 2025
Immuno-μSARS2 Chip: A Peptide-Based Microarray to Assess COVID-19 Prognosis Based on Immunological Fingerprints.
Journal: ACS pharmacology & translational science
Published: December 16, 2024
Targeted nanoliposomes to improve enzyme replacement therapy of Fabry disease.
Journal: Science advances
Published: December 13, 2024
A Cyclic Peptide Targets Glioblastoma by Binding to Aberrantly Exposed SNAP25.
Journal: Molecular pharmaceutics
Published: November 22, 2024
A CYCLIC PEPTIDE TARGETS GLIOBLASTOMA BY BINDING TO ABERRANTLY EXPOSED SNAP25.
Journal: bioRxiv : the preprint server for biology
Published: September 30, 2024
Peptide-Drug Conjugate for Therapeutic Reprogramming of Tumor-Associated Macrophages in Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 26, 2024
Pharmacological activation of insulin-degrading enzyme improves insulin secretion and glucose tolerance in diet-induced obese mice.
Journal: Diabetes, obesity & metabolism
Published: March 05, 2023
Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide.
Journal: International journal of molecular sciences
Published: August 17, 2022
Direct Quantitative Immunochemical Analysis of Autoinducer Peptide IV for Diagnosing and Stratifying Staphylococcus aureus Infections.
Journal: ACS infectious diseases
Published: February 17, 2022
Heterobivalent Ligand for the Adenosine A2A-Dopamine D2 Receptor Heteromer.
Journal: Journal of medicinal chemistry
Published: January 04, 2022
Amide Formation: Choosing the Safer Carbodiimide in Combination with OxymaPure to Avoid HCN Release.
Amide Formation: Choosing the Safer Carbodiimide in Combination with OxymaPure to Avoid HCN Release.
Journal: Organic letters
Published: August 23, 2021
Last Updated: 09/26/2026